Which drug, and when, for patients with BRAF-mutant melanoma?

Title
Which drug, and when, for patients with BRAF-mutant melanoma?
Authors
Keywords
-
Journal
LANCET ONCOLOGY
Volume 14, Issue 2, Pages e60-e69
Publisher
Elsevier BV
Online
2013-01-28
DOI
10.1016/s1470-2045(12)70539-9

Ask authors/readers for more resources

Discover Peeref hubs

Discuss science. Find collaborators. Network.

Join a conversation

Become a Peeref-certified reviewer

The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.

Get Started